|
|
|
Insider
Information: |
Jaen Juan C. |
Relationship: |
President |
City: |
Mountain View |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
371,475 |
|
Indirect Shares
|
1,188,233 |
|
|
Direct
Value |
$6,705,728 |
|
|
Indirect Value
|
$17,906,671 |
|
|
Total
Shares |
1,559,708 |
|
|
Total
Value |
$24,612,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-71.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chemocentryx, Inc. |
CCXI |
SVP, Drug Discovery & ... |
2013-03-08 |
30,000 |
|
0 |
Premium* |
|
Arcus Biosciences Inc |
RCUS |
President |
2024-02-27 |
341,475 |
2024-02-27 |
1,188,233 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-29 |
4 |
AS |
$11.45 |
$56,013 |
D/D |
(4,892) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-31 |
4 |
AS |
$11.45 |
$37,752 |
D/D |
(3,280) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-01 |
4 |
AS |
$11.60 |
$78,106 |
D/D |
(6,725) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-04 |
4 |
AS |
$11.67 |
$45,294 |
D/D |
(3,875) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-07 |
4 |
AS |
$11.65 |
$18,116 |
D/D |
(1,555) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-15 |
4 |
AS |
$11.71 |
$22,825 |
D/D |
(1,945) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-19 |
4 |
AS |
$11.85 |
$184,535 |
D/D |
(15,500) |
45,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-20 |
4 |
AS |
$11.90 |
$66,633 |
D/D |
(5,601) |
45,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-21 |
4 |
AS |
$11.89 |
$13,079 |
D/D |
(1,100) |
45,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-22 |
4 |
AS |
$11.89 |
$90,383 |
D/D |
(7,500) |
45,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-25 |
4 |
AS |
$12.04 |
$92,067 |
D/D |
(7,500) |
45,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-26 |
4 |
AS |
$12.22 |
$92,756 |
D/D |
(7,500) |
45,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-27 |
4 |
AS |
$12.55 |
$94,179 |
D/D |
(7,500) |
45,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-28 |
4 |
AS |
$12.56 |
$66,920 |
D/D |
(5,099) |
45,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-03-04 |
4 |
AS |
$13.96 |
$69,935 |
D/D |
(5,008) |
39,992 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-03-05 |
4 |
AS |
$13.97 |
$41,209 |
D/D |
(2,950) |
37,042 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-03-06 |
4 |
AS |
$13.97 |
$59,329 |
D/D |
(4,247) |
32,795 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-03-07 |
4 |
AS |
$13.95 |
$9,765 |
D/D |
(700) |
32,095 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-03-08 |
4 |
AS |
$13.98 |
$29,284 |
D/D |
(2,095) |
30,000 |
0 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2024-01-02 |
4 |
AS |
$20.09 |
$140,128 |
I/I |
(6,975) |
1,215,265 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2024-02-26 |
4 |
AS |
$20.06 |
$78,234 |
I/I |
(3,900) |
1,211,365 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2024-02-27 |
4 |
AS |
$20.10 |
$464,953 |
I/I |
(23,132) |
1,188,233 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2018-03-19 |
4 |
B |
$15.00 |
$999,990 |
I/I |
66,666 |
2,734,240 |
2.66 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2018-08-09 |
4 |
B |
$11.93 |
$50,855 |
I/I |
4,262 |
2,738,502 |
2.66 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2018-08-10 |
4 |
B |
$11.94 |
$30,796 |
I/I |
2,579 |
2,741,081 |
2.66 |
- |
|
92 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|